Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ocean Biomedical's operating cash flow for the twelve months ending Mar 31, 2025 was -$4.05M. For fiscal 2024 it was -$4.18M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$4.18M | – |
| FY2023 | Dec 31, 2023 | -$9.43M | – |
| FY2022 | Dec 31, 2022 | -$993.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -$356.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.45M | – |
| Q3 FY2024 | Sep 30, 2024 | -$957.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$290.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$485.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$866.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.13M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.78M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.65M | – |
| Q4 FY2022 | Dec 31, 2022 | -$33.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$442.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$151.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$367.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$707.81K | – |
See a number that looks wrong?